WATERTOWN MA December 15, 2022 — InCrowd, a global pioneer of real-time, automated insights for the life science industry and an Apollo Intelligence (Apollo) brand, announced that PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named InCrowd Essentials as one of the most innovative Products of 2022.
InCrowd Essentials is a syndicated market research solution for life science companies that provides an agile, tech-enabled complement to the traditional market tracking study. Life science market tracking methodologies—including custom ATU (Awareness, Trial, and Usage) studies, and traditional syndicated reports—can fall dramatically short of what brand teams need today. InCrowd Essentials puts brand health front and center. It represents a new kind of “packaged” syndicated research solution—one with the ability to pursue optional custom studies later or further explore topics raised by the findings.
With Essentials, brand managers can quickly respond to problems and seize opportunities related to healthcare professional (HCP) product awareness, perceptions, prescribing, and promotional activities. Teams also avoid internal legal and compliance approvals that waylay custom tracking surveys, as well as long waits for insights sourced through traditional ATU tracking studies. By optionally tapping into InCrowd’s micro-research offering, firms can quickly conduct follow-on research with Essentials’ respondents and others to understand nuances that arise from Essentials’ insights.
“InCrowd has spent years tech-enabling the pharma market research process for today’s real-time era, and so we’re particularly pleased that the InCrowd Essentials solution has earned the recognition as one of PM360’s Most Innovative Products of 2022,” said Dan Fitzgerald, CEO and president of Apollo Intelligence, the parent of InCrowd. “Whenever brand health matters, Essentials provides a compelling first stop for syndicated market monitoring.”
InCrowd Essentials was selected as part of PM360’s 11th Annual Innovations Issue published each December. This issue was established to serve as a guide to the year’s most innovative Companies, Startups, Divisions, Products, Services, and Strategies from within the healthcare and life sciences industries. This comprehensive overview of the year’s most innovative achievements in these six categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.
“Our goal for this year’s edition of our annual Innovations Issue was to highlight those in our industry who continue to think big as we emerge from the impact of the pandemic,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “Each of this year’s selections fulfills that goal by delivering big ideas that are resulting in exciting developments across the industry, which can include new therapies, healthcare technology, marketing solutions, clinical trial programs, methods to boost adherence, and much more.”
PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360 evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, 46 total innovations were featured in the issue. Within the Product category, a total of 16 products were featured. All of this year’s selections can be found at: https://www.pm360online.com/pm360-presents-the-2022-innovators.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment. By providing a full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
About Apollo Intelligence, LLC
Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. To complement InCrowd and strengthen its global reach, in 2020, Apollo acquired Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners. For more information about Apollo, please visit our website at www.apollointelligence.net.
Chief Marketing Officer for Apollo Intelligence
Mary Kae Marinac
PR Representative for Apollo Intelligence